Achieve Life Newsroom

Express News | Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer

ReutersDec 9 08:30 ET

Press Release: Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer

Dow JonesDec 9 08:30 ET

Lake Street Sticks to Its Buy Rating for Achieve Life Sciences (ACHV)

TipRanksDec 5 10:22 ET · Ratings

Achieve Life To Advance Cytisinicline Into Phase 3 Study For Vaping Cessation In Q3, 2025

RTTNewsDec 3 10:15 ET

Achieve Life Sciences Announces Outcome of End-of-Phase 2 Meeting With FDA

TipRanksDec 3 08:40 ET

Express News | Achieve Life Sciences Inc - Expects to File Nda for Smoking Cessation in Q2 2025

ReutersDec 3 08:31 ET

Express News | Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting With FDA

ReutersDec 3 08:30 ET

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

Achieve LifeNov 14 08:30 ET

This Turning Point Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

BenzingaNov 14 07:53 ET

Rodman & Renshaw Initiates Achieve Life(ACHV.US) With Buy Rating, Announces Target Price $12

Moomoo NewsNov 14 07:31 ET · Ratings

Express News | Rodman & Renshaw Initiates Coverage On Achieve Life Sciences With Buy Rating, Announces Price Target of $12

BenzingaNov 14 07:03 ET

JonesTrading Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsNov 11 09:31 ET · Ratings

Achieve Life Sciences Poised for U.S. Launch of Cytisinicline With Strong Financial and Strategic Foundations

TipRanksNov 11 09:05 ET

Maxim Group Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsNov 9 10:31 ET · Ratings

Achieve Life Sciences: Promising Future With Strategic Leadership and Strong Financial Position Justifies Buy Rating

TipRanksNov 9 10:25 ET · Ratings

Achieve Life Sciences, Inc. (ACHV) Q3 2024 Earnings Call Transcript Summary

moomoo AINov 9 07:42 ET · Conference Call

Achieve Life Sciences Inc (ACHV) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...

Yahoo FinanceNov 8 14:01 ET

Oppenheimer Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $11

Moomoo NewsNov 8 09:31 ET · Ratings

Oppenheimer Keeps Their Buy Rating on Achieve Life Sciences (ACHV)

TipRanksNov 8 09:06 ET · Ratings

Express News | Achieve Life Sciences Inc Files for Offering of up to 3.5 Mln Common Shares by Selling Stockholders - SEC Filing

ReutersNov 7 16:43 ET